                               SEQUENCE LISTING

<110> JANSSEN BIOPHARMA, INC.
 
<120> POLYNUCLEOTIDE CONSTRUCTS AND USES THEREOF

<130> ALP1010WOPCT1

<140> PCT/IB2021/057497
<141> 2021-08-13

<150> 63/065,487
<151> 2020-08-13

<160> 14    

<170> PatentIn version 3.5

<210> 1
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 1
tcgtcgtttt gtcgttttgt cgtt                                              24


<210> 2
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 2
tcgtcgtttt gtcgttttgt cgtt                                              24


<210> 3
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 3
tcgtcgtttt gtcgttttgt cgtt                                              24


<210> 4
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 4
tcgtcgtttt gtcgttttgt cgtt                                              24


<210> 5
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 5
tcgtcgtttt gtcgttttgt cgtt                                              24


<210> 6
<211> 23
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 6
tcgtcgtttt gtcgttttgt cgt                                               23


<210> 7
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      primer"

<400> 7
gtgtctgcgg cgttttatca                                                   20


<210> 8
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      primer"

<400> 8
gacaaacggg caacatacct t                                                 21


<210> 9
<211> 28
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      probe"

<400> 9
cctctkcatc ctgctgctat gcctcatc                                          28


<210> 10
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 10
tcgtcgtttt gtcgttttgt cgtt                                              24


<210> 11
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 11
tcgtcgtttt gtcgttttgt cgtt                                              24


<210> 12
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 12
tcgtcgtttt gtcgttttgt cgtt                                              24


<210> 13
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 13
tcgtcgtttt gtcgttttgt cgtt                                              24


<210> 14
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 14
tcgtcgtttt gtcgttttgt cgtt                                              24


